baber/WOPTO huggingface dataset:
Patent CA-2497405-A1 (CA)
Title: Method for statistical disclosure limitation
Inventor: SINGH AVINASH C
IPC: G06F17/30
Filed: 2003-09-03
Abstract: A method and system for ensuring statistical disclosure limitation (SDL) of categorical or continuous micro data, while maintaining the analytical quality of the micro data. The new SDL methodology exploits the analogy between (1) taking a sample (instead of a census), along with some adjustments, including imputation, for missing information, and (2) releasing a subset, instead of the original data set, along with some adjustments for records still at disclosure risk. Survey sampling reduces monetary cost in comparison to a census, but entails some loss of information. Similarly, releasing a subset reduces disclosure cost in comparison to the full database, but entails some loss of information. Thus, optimal survey sampling methods can be used for statistical disclosure limitation. The method includes partitioning the database into risk strata, optimal probabilistic substitution, optimal probabilistic subsampling, and optimal sampling weight calibration.
Patent CA-2498183-A1 (CA)
Title: High concentration topical insecticide containing pyriproxyfen
Inventor: COTTRELL IAN WILLIAM
IPC: A01N47/40
Filed: 2003-09-11
Abstract: A topical insecticide is provided which can be safe to use and avoids many common deleterious side effects of conventional topical insecticides. In one preferred embodiment of the invention, the active ingredient of the insecticide formulation is an amine derivative, having a nitro-methylene group, a nitroamino group or a cyanoamino group, which can be formulated to have low toxicity and excellent insecticidal activity. One particularly suitable insecticide is 1-{(tetrahydro-3-furanyl)methyl}-2-nitro-3- methylguanidine (dinotefuran), an aldulticide that will kill adult fleas combined with pyriproxyfen.
Patent CA-2498627-A1 (CA)
Inventor: CHAO TIMOTHY
IPC: C01B33/149
Filed: 2003-09-05
Abstract: L'invention concerne un procédé de préparation d'une silice colloïdale partiellement agglomérée hydrophobe. Ledit procédé consiste à faire réagir (a) un sol siliceux renfermant au moins une silice colloïdale partiellement agglomérée hydrophile avec (b) un composé d'organosilicium sélectionné parmi (i) au moins un organosilane de formule R?1¿¿a?H¿b?SiX¿4-b?, (ii) au moins un organocyclosiloxane de formule (R?1¿¿2?SiO)¿m?, (iii) au moins un organosiloxane de formule R?1¿¿3?SiO(R?1¿SiO)¿n?SiR?1¿¿3?, et (iv) un mélange contenant au moins deux éléments parmi (i) (ii), et (iii), en présence (c) d'eau, (d) d'une quantité efficace d'un solvant organique miscible dans l'eau, et (e) d'un catalyseur acide, en vue de produire la silice colloïdale partiellement agglomérée hydrophobe et une phase aqueuse. R?1¿ représente un hydrocarbyle ou un hydrocarbyle substitué, X représente un groupe hydrolysable, a est égal à 0, 1, 2, ou 3, b est égal à 0 ou 1, a + b = 1,2, ou 3, à condition que lorsque b = 1, a + B = 2 ou 3; m possède une valeur moyenne comprise entre 3 et 10, et n présente une valeur moyenne allant de 0 à 10. Cette invention a aussi pour objet la silice colloïdale partiellement agglomérée hydrophobe produite par le procédé susmentionné, une composition de silicone à charge qui renferme (A) une composition de silicone durcissante et (B) entre 5 et 60 % en poids d'une silice colloïdale partiellement agglomérée hydrophobe, ainsi qu'un produit de silicone durci contenant un produit de réaction de la composition de silicone avec charge.
Patent CA-2500331-A1 (CA)
Inventor: MUHLE MICHAEL E
IPC: C08F2/00
Filed: 2003-08-28
Abstract: L'invention concerne des revêtements de parois de réacteur pour réacteurs de polymérisation et des procédés appropriés pour produire des revêtements de ce type. Les revêtements de parois de réacteur peuvent présenter une épaisseur inférieure à 100 µm et une répartition de poids moléculaire comprenant une crête principale ayant : un rapport Mw/Mn inférieur à 10 ; un rapport Mz/Mw inférieur à 7 et une valeur maximale de d( % en poids)/d(log MW) inférieure à 25.000 daltons dans un graphique de d( % en poids)d(log MW), MW désignant le poids moléculaire en daltons. Les revêtements de parois de réacteurs peuvent être formés in situ au cours de la polymérisation, sur des parois de réacteur initialement exemptes de revêtement de paroi de réacteur ou comportant un revêtement de paroi de réacteur préexistant.
Patent CA-2501246-A1 (CA)
Title: Container for shipping and storing paper
Inventor: WAITE DALE J
IPC: B65D5/20
Filed: 2003-09-05
Abstract: A container (10) for shipping and/or storing a stack of paper is disclosed. The container, according to a disclosed embodiment, comprises a bottom wall (14) and first (16) and second (18) upright, opposing side walls extending from respective edges (20,22) of the bottom wall. First (24) and second (26) shell portions are connected in a pivotal manner to respective edges (28,30) of the bottom wall. The shell portions are pivotable toward and away from ea ch to close and open the container, respectively. When the container is closed, the stack is securely contained between the shell portions and the side wall s for shipping or storing. When the container is opened, at least two opposing sides of the stack are exposed to facilitate removal of paper from the container. A handle (57) for carrying or lifting the container may be couple d to one of the shell portions.
Patent CA-2503888-A1 (CA)
Title: Chimeric cytoplasmic signalling molecules
Inventor: LAWSON ALASTAIR DAVID GRIFFITH
IPC: C07K14/705
Filed: 2003-10-28
Abstract: Nucleic acids are described which code for chimeric cytoplasmic signalling molecules containing at least one cytoplasmic signalling sequence derived fr om CD134 or ICOS. The nucleic acids may be expressed in cells to produce chimer ic receptors and other proteins which are able to regulate cell activation processes. Such regulated cells are of use in medicine, for example in the treatment of infectious, inflammatory and autoimmune diseases.
Patent CA-2509494-A1 (CA)
Inventor: CZECH MICHAEL P
IPC: C12N15/87
Filed: 2003-12-11
Abstract: Il s'avère, en général, difficile d'introduire des séquences d'acide nucléique dans des adipocytes. Selon cette invention, les procédés d'introduction des acides nucléiques tels que les siRNA dans des adipocytes comprennent l'introduction de séquences ciblant Akt1, Akt2 et Myo1c. L'invention porte également sur des procédés d'identification de gènes impliqués dans le transport du glucose et sur des procédés d'identification de modulateurs de la réponse insulinique. L'invention porte, en outre, sur des méthodes thérapeutiques.
Patent CA-2511822-A1 (CA)
Inventor: HOUZE DAVID
IPC: B65D75/52
Filed: 2003-12-29
Abstract: A product retention package (10) is disclosed, wherein the package is configured to form a sealed internal cavity (16) for receiving a product (18 ), particularly transdermal delivery systems, patches, bandages, films, sheets, and the like. A retention means (20,26) is formed in association with the cavity to maintain the position of the product distal to a predetermined opening location. By controlling the position of the product within its packaging, the user can more easily and safely open the package at its predetermined opening location without damaging the product.
Patent CA-2514037-A1 (CA)
Title: Crystalline modification of 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-n-methyl-isobutyramide
Inventor: WALDMEIER PIUS
IPC: A61P25/00
Filed: 2004-01-23
Abstract: The present invention relates to a new crystalline modification of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-N-methyl-isobutyramide characterized by the following X-ray diffraction pattern obtained with a CUK.alpha.radiationat 2.theta. (2Theta)= 4.5, 6.4, 7.5, 7.7, 8.0, 8.2, 10.0, 10.2, 10.9, 11.1, 12.9, 13.4, 14.0, 14.5, 15.1, 15.6, 16.2, 16.5, 17.3, 17.5, 18.0, 18.9, 19.3, 19.5, 19.9, 20.1, 20.6, 21.0, 21.4, 22.7, 23.1 and 23.6 and an infrared spectrum having sharp bands at 2925, 2845, 1637, 1604, 1484, 1395, 1375, 1285, 1230, 1172, 1125, 1082, 999, 943, 893, 863, 860, 782, 705, 684 cm-1, and wherein the extrapolated melting point (DSC) is 137.2~C.
Patent CA-2514350-A1 (CA)
Inventor: CUMMINGS WILLIAM J
IPC: B81C1/00
Filed: 2005-07-29
Abstract: An etching chamber is configured to support a MEMS substrate within the chamber. The etching chamber is configured to be relatively easy to move and attach to an etch station that includes a source of vapor or gaseous etchant, a source of purge gas and/or a vacuum source. The portable etching chamber may facilitate a process for etching the MEMS  substrate contained therein. For example, a MEMS substrate in such an etching chamber may be etched by connecting the chamber into an etch station and exposing the MEMS substrate to an etchant in order to etch the MEMS substrate. The substrate can be moved to or from the etch station within the portable etching chamber. In preferred embodiments, the MEMS substrate is an interferometric modulator and the etchant is XeF2.
Patent CA-2514411-A1 (CA)
Title: Jardiniere modulaire equipee d'un systeme d'evacuation d'eau, et collier-support de connexion des modules adapte pour la mise en place de l'element d'eclairage
Inventor: GONZALEZ MIGUEZ JOSE
IPC: A01G9/02
Filed: 2003-01-31
Abstract: L'invention concerne une jardinière modulaire à double paroi permettant l'évacuation de l'eau excédentaire de l'arrosage, ainsi que la ventilation des racines et de la terre, équipée de colliers-supports de connexion des modules longitudinaux, avec ou sans renfort, et angulaires, de préférence selon des angles de 901 ou 1351, ainsi que de couvercles de fermeture placés sur les extrémités des modules, le tout formant un ensemble jardinière unique, pouvant être facilement monté, avec une structure solide et étanche, et permettant d'installer un arrosage automatique.
Patent CA-2514629-A1 (CA)
Title: Method and apparatus for remote control
Inventor: FITZGIBBON JAMES J
IPC: G08C17/02
Filed: 2004-02-12
Abstract: An access requesting remote control device (10) includes an agile radio frequency transmitter (13) that will accommodate a variety of communication channels and modulation types. Programmable logic (11) controls the operation of the transmitter depending upon its programming. Such programming can be selectively varied as desired. In one embodiment, any of a plurality of pre-existing application programs can be selected in response to reception of a corresponding selection command via an external communication interface (14).  In another embodiment, a relevant application program can be downloaded to the programmable logic via the external communication interface. In yet another embodiment, both options are available.
Patent CA-2515649-A1 (CA)
Inventor: BARKDOLL PATRICK J
IPC: B27C5/10
Filed: 2004-02-11
Abstract: The present invention is directed toward a quick attach and detach mechanism for a tool attachment such as a router attachment for a router. The attachment system includes a mounting adapter which may be integrally formed with the router housing or attached to the router housing as a bolt-on plate. The system works by vertically installing the tool attachment with the mounting adapter and then twisting to secure the tool attachment to the mounting adapter. A rotational lock is provided to prevent the tool attachment from inadvertently backing off or coming loose. This lock can be manually actuated to allow for quick detachment when desired. The tool attachment system is shown in association with a router which has several disclosed benefits, however there may also be applications of the system in other types of tool attachments for which coverage is also sought.
Patent CA-2517083-A1 (CA)
Inventor: LE POUL EMMANUEL
IPC: C07D213/74
Filed: 2004-03-04
Abstract: The invention relates to novel aminopyridine derivatives of formula (I) wherein R1 is methyl an R 4  and amino group - NR 6 R 7  and R 5  forms an arylalkynyl- or heteroarylalkynyl-group. The compounds are useful in the prevention or treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.
Patent CA-2517173-A1 (CA)
Title: Method and appartus for optimizing cardiac resynchronization therapy based on left ventricular acceleration
Inventor: CHINCHOY EDWARD
IPC: A61N1/362
Filed: 2004-02-19
Abstract: A system and method for monitoring left ventricular cardiac contractility and for optimizing a cardiac therapy based on left ventricular lateral wall acceleration (LVA) are provided. The system includes an implantable or external cardiac stimulation device in association with a set of leads including a left ventricular epicardial or coronary sinus lead equipped with an acceleration sensor. The device receives and processes acceleration sensor signals to determine a signal characteristic indicative of LVA during isovolumic contraction. A therapy optimization method evaluates the LVA during varying therapy settings and selects the setting(s) that correspond to a maximum LVA during isovolumic contraction. In one embodiment, the optimal inter-ventricular pacing interval for use in cardiac resynchronization therapy is determined as the interval corresponding to the highest amplitude of the first LVA peak during isovolumic contraction.
Patent CA-2518598-A1 (CA)
Title: Gaming apparatus having a display with a conductive coating
Inventor: CRISS-PUSZKIEWICZ CYNTHIA
IPC: G07F17/32
Filed: 2004-03-15
Abstract: A gaming apparatus comprising a housing, a transparent panel with a first and second surface, and a conductive coating disposed proximate to the second surface, wherein the coating has a high visible light transmittance and a low electrical surface resistance. The gaming apparatus also comprises a grounded metallic strip coupled to the coating and located at a perimeter of the coating, a value input device, and a mechanically rotatable reel that is disposed in the housing so that the mechanically rotatable reel is visible to a player of the gaming apparatus through the transparent panel and the coating. Also included is a controller that comprises a processor and a memory coupled to the processor. The controller is programmed to allow a person to make a wager and to determine a value payout associated with an outcome of a game incorporating the mechanically rotatable reel.
Patent CA-2521156-A1 (CA)
Title: Antibodies as growth promoting agents
Inventor: HARE JOHN
IPC: A61K35/57
Filed: 2005-09-16
Abstract: Animal feed is supplemented with antibody-containing egg powder as a means of improving growth of animals.
Patent CA-2522162-A1 (CA)
Title: Method for simulating drilling of roller cone bits and its application to roller cone bit design and performance
Inventor: HUANG SUJIAN
IPC: E21B44/00
Filed: 2001-03-12
Abstract: A method for simulating the drilling performance of a roller cone bit drilling an earth formation may be used to generate a visual representation of drilling, to design roller cone drill bits, and to optimize the drilling performance of a roller cone bit. There is provided a method for optimizing a design of a roller cone drill bit, comprising simulating the bit drilling through a selected earth formation; adjusting at least one design parameter of the bit; repeating the simulating the bit drilling; and repeating the adjusting and simulating until an optimized design is determined. There is also provided a method for designing a roller bit cone, comprising simulating the drill bit drilling through an earth formation, the simulating comprising determining, based on a means for determining an axial force, an axial force acting on each of the cutting elements, determining the axial force acting on each of the roller cones, based on the axial force acting on the cutting elements, rotating the bit and redetermining the axial forces acting on each of the cutting elements, repeating the rotating and redetermining for a number of rotations, and adjusting at least one bit design parameter, and repeating the simulating and adjusting until a difference between the axial force on each one of the roller cones is less than a difference between the axial force determined prior to adjusting the at least one initial design parameter.
Patent CA-2524454-A1 (CA)
Title: Enzyme with xylanase activity at acidic ph
Inventor: COPPE PHILIPPE
IPC: A23L2/84
Filed: 2004-05-28
Abstract: The present invention is related to an isolated and purified enzyme with xylanolytic activity having more than 70% of sequence identity with the amino acid sequence SEQ ID NO 8.
Patent CA-2525821-A1 (CA)
Title: Method and apparatus for odu to idu telemetry interface in vsat systems
Inventor: MILLER MARK J
IPC: H04H40/90
Filed: 2004-04-14
Abstract: A single cable inter-facility link (16) is provided using an IDU-ODU telemetry interface employing an encoder in the status transmit circuitry (103) and in the control transmit circuitry (102) which encodes the appropriate data by integrating Manchester encoding, a preamble and postamble, and on-off keying to create a unique data packet scheme which is compatible with any existing inter-facility link protocol and which does not interfere with the DC power or normal data traffic. Together with a simple receiver structure implementing an adaptive threshold detector that decodes the telemetry data, any kind of information can be communicated between the IDU (12) and ODU (14) over a single cable (16). Control of the ODU (14) by the IDU (12) via a bi-directional half-duplex or full-duplex telemetry interface allows the IDU (12) to control the ODU settings.
Patent CA-2526587-A1 (CA)
Inventor: KAJIURA NORIKO
IPC: C09D11/00
Filed: 2004-05-20
Abstract: A magenta pigment represented by the following formula (1) which has hue and definition suitable for inkjet recording and enables to obtain a recorded matter that is excellent in fastness to light, gas, water and the like is disclosed. An ink composition using such a pigment is also disclosed. (wherein the symbols are as defined in the description.)
Patent CA-2526771-A1 (CA)
Title: Synthesis of high molecular weight iron-saccharidic complexes
Inventor: BECK ROBERT A
IPC: A61K31/715
Filed: 2004-05-28
Abstract: A process for preparing parenteral iron-saccharidic complexes, and the complexes produced, comprising: (1) providing an aqueous solution or dispersion including (i) Fe (III) and (OH)- ions and (ii) at least one saccharide, to form a reaction mixture, where the molar ratio of (i): (ii) is about 30:1 to about 1:30; and the mixture temperature and pH are at or above the complex assembly point (CAP); and (2) maintaining temperature and pH at or above the CAP for a time sufficient to form an iron-saccharidic complex having a molecular weight of about 25,000 Daltons or more. Control of the temperature and pH efficiently produces a high molecular weight complex. The complex can be separated by precipitation, dialysis and/or column fractionation and, if desired, dried, e.g., lyophilized or spray dried. The process can controllably synthesize complexes of varying molecular weight and/or chemical composition, particularly sodium ferric gluconate and ferric hydroxide-sucrose.
Patent CA-2527610-A1 (CA)
Inventor: TIEVANT PHILIPPE
IPC: E02D29/14
Filed: 2005-11-18
Abstract: La présente invention concerne un dispositif permettant de verrouiller amoviblement un tampon ou un couvercle sur un cadre. Selon l'invention, la rondelle métallique (9), interposée entre la tête de vis (4) et la face d'appui (7) formée au fond du logement (5) du couvercle (2), comprend deux ailettes radiales diamétralement opposées (9a) coopérant avec des parties internes (13) du logement (5) formant butées et empêchant une rotation de la rondelle (9) lors du serrage de la vis de fixation (3). L'invention trouve application dans le domaine de la voirie.
Patent CA-2528686-A1 (CA)
Title: Dna-based aptamers for human cathepsin g
Inventor: GATTO BARBARA
IPC: A61K38/00
Filed: 2004-06-18
Abstract: The present research is directed to the identification of non-peptidic inhibitors of cathepsin G characterised by high levels of selectivity and which can be efficaciously used in the treatment and prophylaxis of inflammatory occurrences and procoagulant conditions. The cathepsin G-inhibiting aptamers according to the invention consist of linear DNA or polynucleotide sequences having a chaing length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing.
Patent CA-2529124-A1 (CA)
Title: Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
Inventor: LAZZARINI AMERIGA
IPC: A23K20/195
Filed: 2004-07-12
Abstract: The invention relates to an antibiotic substance of microbial origin, arbitrarily denominated antibiotic 107891 which is produced by fermentation of Microbispora sp. ATCC PTA-5024, the pharmaceutically acceptable salts and compositions thereof, and their use as an antibacterial agent having inhibitory activity versus susceptible microbes. Antibiotic 107891, which is a complex comprising two Factors, denominated Factors Al and A2, has a peptide structure containing lanthionine and methyllanthionine as constituents which are typical characteristics of the antibiotics of the lantibiotics group.  Antibiotic 107891 and its Factors Al and A2 show a good antibacterial activity against Gram-positive bacteria including methicillin resistant and van comycin resistant strains, and is active also against some Gram-negative bacteria suchas M. catharralis, Neisseria species and H. influenzaeand Mycobacteria.
Patent CA-2531784-A1 (CA)
Title: Boites pour l'exhibition de medailles ou medaillons avec rubans et de leur assemblage en structures diverses
Inventor: BELZILE FRANCOIS M
IPC: A47G1/12
Filed: 2006-01-10
Abstract: A modular system for the display of medals or medallions with neck ribbons or chains. The invention comprises a primary and a secondary embodiment wherein the primary embodiment depicts a tower system, and the secondary embodiment depicting and wall mount system, which both utilize the ribbon attachment methods of the present invention. Each embodiment utilizes: one or more modular boxes, which can be stacked where rnedais can be displayed on the outside vertical faces of each exterio r box face, a top portion to enclose the upper module, and a base to provide seating and elevation of the modules. The ribbons are attached individually on the upper interior side portion of the box by means of ribbon-clamping devices, which permit easy positioning and attachment. The unused length of ribbon is conceaied within the box cavity. A lighted mechanical rotating base is also described.
Patent CA-2531862-A1 (CA)
Title: Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
Inventor: RYAN ANDERSON JOSEPH
IPC: A61K33/243
Filed: 2004-07-07
Abstract: The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer, particularly a cancer involving a solid tumour, which comprises the administration of ZD6474 in combination with a platinum anti-tumour agent; to a pharmaceutical composition comprising ZD6474 and a platinum anti-tumour agent; to a combination product comprising ZD6474 and a platinum anti-tumour agent for use in a method of treatment of a human or animal body by therapy; to a kit comprising ZD6474 and a platinum anti-tumour agent; to the use of ZD6474 and a platinum anti-tumour agent in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation.